AR226-2711 RECYCLED AR226-2711 Observed Metabolites of Telomer 8-2 Alcohol Parent Compound: F iC F j^C H jC H jO H Observed Mammalian Metabolites F(CF2)gCOOH F(CF2)7COOH Note: We have not yet looked for mammalian metabolites with less than an 8-carbon chain.
refid# 44Jq5x0O5GEz1OaXa1oxkab3V2 pages
3M Katherine E.
refid# 5De2Ljad9aQdq48e0EyEZJOwD2 pages
Material Tested: Material Submitted by AR226-2748 Copies to: E.
refid# 6bVpgOBZj56BjY5E9LL7OpjOd2 pages
FOR DU PONT USE ONLY cc : AR226-2908 .
refid# QMgy9nB1xajG95Jg305Eo7dLv5 pages
FOR DU PONT SE ONLY AR226-2939 Du Pont HLR 360-89 Study Title Skin Irritation Test in Rabbits o Author John W.
refid# 1QeBzXyMXXGvXpnv7kQNLXbZK8 pages
t i AR226-3023 Study T i t l e 100-Person Hunan Patch Test with H-21275 (Control Item), H-21273 (Test Item 1), and H-21274 (Test Item 2) Laboratory Project ID Haskell Laboratory Report No. 447-95 Study Completed On August 24, 1995 Contracting Laboratory Biosearch, Incorporated 3408-50 B Street Philadelphia, Pennsylvania 19134 Author James E.
refid# 2JJge4jxLk6m92d4Vag755Oq632 pages
AR226-3042 Study.Titfe Skin Irritation Test with H-2I987 in Rabbits Laooratorv Project ID Haskell Laboratory Report No. 605-96 Author Carol Finlay Study Completed On August 26,1996 Performing Laboratory E.
refid# YGVQMDNvwa9MpK64LBMxkLrE010 pages
.
refid# by27Zbrg5O16NnnMG42bqvby619 pages
M ate- 33or 487 DuPont Haskell Laboratory for Health and Environmental Sciences TO: FROM: MR FILI POCKET H-24921 J.
refid# ExwJBJd5mgx1jY3zLqawO0e2N5 pages
Z 6T 000 et b r i ' W W CONFIDENTIAL MEMO TO: F, E.
refid# daapop62GKQD5Q5OXrqyZJZQG4 pages
rcoo 000218 HToaxsikceollloLgaybaonrdatIonrdyufsotrrial Medicine 1090 Elfctan Road Newark,DE 19714 Date: To: Cc: Subject: Septem ber 23,1999 Barbara Dawson C-8 Surveillance From: Robin C.Leonard Epidemiology Prog I have iooked at the results o f the first sam ple of measurements from the C -8 surveillance project at Cham bers W orks, A s would be expected for base-line sam ples, there is very little analysis that can be done at this point It is possible, however, to note a few things about the distributions of the measurements.
refid# baQjVx0y2rgkRJgQq8Dg820862 pages
RECEIVED irrt cno OfrJUL-5 AHII: 22 AK 2Z _ 373Z Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing Workers Final Report Bruce H.
refid# NmgD2dDOJeB6vD1key8XLq7826 pages
M 2 S 6 _ 373C Andrea V.
refid# 8O7BqZ4pVZjw88G73DjnRwoKd3 pages
ATSttCn:A SDeocctuiomne8n(et)P/FroYcIessing Center Attachment 1 P-1 P-1 July 28,2006 Page 4 of 5 M Z26 _373J- Acronym codefor Tables 1 and 2 In Tables 1 and 2, the following acronyms are used: acronym meaning CW FW WW DuPont Chambers Works facility in Deepwater, New Jersey DuPont Fayetteville Works facility in Fayetteville, North Carolina DuPont Washington Works facility in Parkersburg, West Virginia PPPFFFHPBeAxAA PFHpA PPPPFFFFOUDNnAAAA PFDoA PFBS PPPFFFOHOSxSSA PPeerrfflluuoorroobpuentatannooicicaacicdid Perfluorohexanoic acid Perfluoroheptanoic acid Perfluorooctanoic acid Perfluorononanoic acid Perfluorodecanoic acid Perfluorotmdecanoic acid PPPeeerrrfffllluuuooorrrooobhdueoxtdaaennceaenssuoulilfcfooanncaaitdtee Perfluorooctane sulfonate Perfluorooctane sulfonamide Attachment 1 Spaed Matrix Lab Blank 1 cw # P % cw p 3 cw n m 34 CW (DUPLICATE) c w v 5 cw i cw < P * CW 7 cw qp ( CW WG18817-102 Y2 WG18817-101 Y1 L8789-1 Y1 LB789-2 Y1 L87B9-3 Y1 WG18817-103Y1 L8789-4 Y1 L8789-5 Y1 LB789-5 Y1 LB789-6 Y1 L8789-7 Y1 L8789-8 Y1 % Recovery ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL WQ18817 W Q 18817 WQ18817 WQ18817 WG18817 WG18817 WG18817 WG18817 WG18817 WG18817 WG18817 WG18817 PFBA 81.2 ND ND ND ND ND ND <1.44 <1.44 <1.44 NO ND PFPeA 79.0 ND ND ND ND ND ND ND NO ND ND ND PFHxA 85.8 ND 1.82 ND <0.900 <0.900 ND ND ND <0.900 ND <0.900 PFHpA 83.5 ND ND ND ND ND <1.41 3.71 3.71 11.7 6.91 ND PFO A 110 ND 7.71 9.72 24.1 21.6 42.8 13.4 13.4 111 56.7 26.6 PFNA 11B ND 4.28 2.90 7.10 6.78 18.3 4.22 4.22 53.1 29.2 2.37 PFDA 115 ND <1.06 <1.08 1.64 1.51 8.47 1.82 1.82 13.5 7.47 <1.08 PFUnA 128 ND <1.02 <1.02 2.37 2.60 1.70 <1.02 <1.02 3.99 1.55 ND PFDoA 60.9 ND ND ND <0.600 <0 600 0.943 <0.600 <0.600 1.10 0.737 ND PFBS 94.8 ND ND ND ND ND ND ND ND ND ND ND PFHxS 104 ND <3.72 <3.72 39.1 33.5 <3.72 <3.72 <3.72 4.28 <3.72 3.81 PFOS 112 ND 51.1 35.3 68.2 58.0 25.7 35.0 36.0 39.0 53.8 36.8 PFO SA 73.5 ND ND ND ND ND ND ND ND NO ND ND Attachment 1 PFBA PFPeA PFHxA PFHpA PFOA PFNA PFDA PFUnA PFDoA PFBS PFHxS PFOS PFOSA tp // CW ^ k F w t f f lV L8789-9 Y1 LS789-10Y1 L8789-11 Y1 ngftnL ngAnL WG1B817 WG18817 ngAmL WG18817 ND ND NO ND ND ND ND ND ND NO 1.48 ND 12.9 13.0 28.3 <1.53 3.97 2.28 ND <1.08 <1.08 ND <1.02 <1.02 ND ND ND ND ND ND <3.72 <3.72 6.64 30.7 46.9 37.2 ND ND ND t-2.
refid# jm5v0kRxZnepBn7944Ev4anBO4 pages
P-1 TSCADocument Processing Center Attn: Section 8(eVFYI yf fL 7 - 7 i- 3 7 3 S Attachment 2 p- 2 July 28,2006 Page 5 of 5 Axys Analytical Services Laboratory - Form 1A and Form 2 (2 pages) P-2 P-3 s r.......... 7 ' "r *'*.".* *'"' ______;______
refid# nkrLJR0eNNKNkoJpZeojy5YOm3 pages